Management of Helicobacter pylori infection: Gastroenterological and surgical perspectives

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 581-590

  Maconi, G ^b   Kurihara, H ^a   Taschieri, A M ^a   Bianchi Porro, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale L Sacco ^*

Author keywords

Gastric cancer; Gastric ulcer; Helicobacter pylori; Peptic ulcer; Ulcer

Indexed keywords

CANCER SURGERY; CONFERENCE PAPER; DYSPEPSIA; GASTRODUODENAL ULCER; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; STOMACH CANCER; STOMACH SURGERY;

EID: 0033382281     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.581     Document Type: Conference Paper

References (85)

1. 1 Knill Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991; 26 (Suppl.182): 17-24.
2. 2 The European Helicobacter pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997; 41: 8-13.
3. 3 Zar S, Mendall MA. Clinical practice - Strategies for management of dyspepsia. In: British Medical Bulletin. Helicobacter pylori infection. Farthing MJG, Patchett SE, Eds. London: Royal Society of Medicine Press Limited, 1998:217-229.
4. 4 Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996; 31 Suppl 215: 38-47.
5. 5 Elta G, Scheiman J, Barnett J, et al. Long term follow-up of Helicobacter pylori treatment in non ulcer dyspepsia patients. Am J Gastroenterol 1995; 90:1089-1093.
6. 6 Lazzaroni M, Bargiggia S, Sangaletti O, et al: Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Dig Dis Sci 1996; 41: 1589-1594.
7. 7 McCarty C, Patchett S, Collins RM, et al. Long term prospective study of Helicobacter pylori in non ulcer dyspepsia, Dig Dis Sci 1995; 40: 114-119.
8. 8 Trespi E, Broglia F, Villani O, et al. Distinct profiles of gastritis in dyspepsia subgroups. Their clinical response to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol 1994; 29: 884-888.
9. 9 McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non ulcer dyspepsia. N Engl J Med 1998; 339: 1869-1874.
10. 10 Bum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating Helicobacter pylori infection in patients with non ulcer dyspepsia. N Engl J Med 1998; 339: 1875-1881.
11. 11 Pace F, Bianchi Porro G. Gastro-oesophageal reflux and Helicobacter pylori. It J Gastroenterol Hepatol 1998; 30 (Suppl 3): s289-s293.
12. 12 Labenz L, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infction in patints with duodenl ulcer may provoke reflux esohagitis. Gastroenterology 1997; 112: 1442-1447.
13. 13 Lazzaroni M, Bargiggia S, Maconi G, et al. H. pylori eradication and the risk of oesophagitis in duodenal ulcer and dyspeptic patients. It J Gastroenterol Hepatol 1997; 29 (Suppl.2): A124.
14. 14 Verdu E, Armstrong D, Idstrom JP, et al. Effect of curing Heticobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-748.
15. 15 Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-732.
16. 16 Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022.
17. 17 Misiewicz JJ. Management of Helicobacter pylori-related disorders. Eur J Gastroentrol Hepatol 1997; 9(Suppl.1): s17-s21.
18. 18 Hentschel E, Brandstatter G, Dragosic B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
19. 19 Hosking SW, Ling TKW, Yung YM, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Brit Med J 1992; 305: 502-504.
20. 20 Bayerdorffer E, Miehlke S, Mannes GA, et al. Doubleblind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-1417.
21. 21 Seppala K, Pikkarainen P, Sipponen P, et al. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Gut 1995; 36; 834-837.
22. 22 Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19-22.
23. 23 Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-510.
24. 24 Suriani R, Ravizza M, Pallante C, et al. Helicobacter py/ori-positive duodenal ulcer: a long term double blind randomized study in patients healed with H2-receptor antagonists. Helicobacter 1996; 1: 151-154.
25. 25 NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
26. 26 Fendrick MA, McCort JT, Chernew ME, et al. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. Am J Gastroenterol 1997; 92: 2017-2024.
27. 27 Miehlke S, Bayerdorffer E, Lehn N, et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 975-978.
28. 28 Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up. Lancet 1994; 343: 258-260.
29. 29 Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1785-1788.
30. 30 van Der Hulst RWM, Rauws EAJ, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113: 1082-1086.
31. 31 Tursi A, Cammarota G, Papa A, Montalto M, Fedeli G, Gasbarrini G. Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. J Clin Gastroenterol 1996; 23: 157-158.
32. 32 Annibale B, Marignani M, Luzzi I, Delle Fave GF. Peptic ulcer and duodenal stenosis: role of Helicobacter pylori infection. Ital J Gastroenterol 1995; 27: 26-28.
33. 33 Lam Y, Lau JY, Law KB, et al. Endoscopic balloon dilation and Helicobacter pylori eradication in the treatment of gastric outlet obstruction. Gastrointest Endosc 1997; 46: 379-380.
34. 34 de Boer WA. Resolution of gastric outlet obstruction after eradication of Helicobacter pylori. J Clin Gastroenterol 1995; 21: 329-330.
35. 35 Tokunaga Y, Hata K, Ryo J, et al. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg 1998; 186: 659-663.
36. 36 Sebastian M, Chandran VP, Elashaal YI, Sim AJ. Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg 1995; 82: 360-362.
37. 37 Mihmanli M, Isgor A, Kabukcuoglu F, et al. The effect of H. pylori in perforation of duodenal ulcer. Hepatogastroenterology 1998; 45: 1610-1612.
38. 38 Reinbach DH, Cruckshank G, McColl KEL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 13: 44-47.
39. 39 Chowdhary SK, Bhasin DK, Panigrahi D, et al. Helicobacter pylori infection in patients with perforated duodenal ulcer. Trop Gastroenterol 1998; 19: 19-21.
40. 40 Matsukura N, Onda M, Tokunaga A, et al. Role of Helicobacter pylori infection in perforation of peptic ulcer: an age-and gender-matched case-control study. J Clin Gastroenterol 1997; 25 (Suppl 1): S235-239.
41. 41 Ng EK, Chung SC, Sung JJ, et al. High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs. Br J Surg 1996; 83: 1779-1781.
42. 42 Debongnie JC, Wibin E, Timmermans M, Mairesse J, Dekoninck X. Are perforated gastroduodenal ulcers related to Helicobacter pylori infection? Acta Gastroenterol Belg 1995; 58: 208-212.
43. 43 Donovan AJ, Berne TV, Donovan JA. Perforated duodenal ulcer: an alternative therapeutic plan. Arch Surg 1998; 133: 1166-1171.
44. 44 Lai KC, Hui WM, Lam SK. Bleeding ulcers have high false negative rates for antral Helicobacter pylori when tested with urease test. Gastroenterology 1996; 110: A167.
45. 45 Buckley M, Lee J, O'Morain C. The problem ulcer; bleeding, perforation, Helicobacter pylori negativity and intractability. In: Hunt RH, Tytgat GNJ (eds), Helicobacter pylori: Basic Mechanisms to Clinical Cure, Dordrecht, Kluwer Academic Publishers, 1996: 295-303.
46. 46 Hosking SW, Yung MY, Chung SC, Li ARC. Differing prevalence of Helicobacter in bleeding and nonbleeding ulcers. Gastroenterology 1992; 102: A85.
47. 47 Carasquillo-Garcia RJ, Stevens PD, Lighdale CJ, et al. The prevalence of Helicobacter pylori in patients with bleeding ulcers. Gastroenterology 1996; 110: A113.
48. 48 Illies G, Nilius M, Dominguez-Munoz JE, et al. Helicobacter pylori antibodies against CagA protein in bleeding and nonbleeding gastric and duodenal ulcers. Gut 1996; 39, (Suppl.3): A120.
49. 49 Ng EKW, Chung SCS, Sung JY, et al. Helicobacter is the major cause for non-NSAID-related duodenal and prepyloric ulcer perforations. Gastroenterology 1996; 110: A211.
50. 50 Pilotto A, Leandro G, Di Mario F et al. Role of Helicobacter pylori (Hp) infection and NSAID use on upper GI tract bleeding in the elderly. Gastroenterology 1996; 110: A230.
51. 51 Henriksson AE, Edman AC, Held M, Wadstrom T. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol 1995; 7(8): 769-771.
52. 52 Leung WK, Sung JJ, Siu KL, et al. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998; 93: 1914-1918.
53. 53 Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-942.
54. 54 Labenz J, Bosch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
55. 55 Jaspersem D, Koerner T, Schorr W, et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest Endosc 1995; 41: 5-7.
56. 56 Rokkas T, Karameris A, Mavrogeorgis A, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
57. 57 Salandin S, Del Bo N, Grassi SA, et al. Eradication of H. pylori infection in preventing duodenal ulcer bleeding: one year interim report in a prospective five year study. Gut 1996; 39 (Suppl 2): A28.
58. 58 Pazzi P, Dalla Libera M, La Froscia A, et al. Helicobacter pylori eradication reduces rebleeding rate in peptic ulcer disease. Gastroenterology 1996; 110: A224.
59. 59 Macri G, Milani S, Surrenti E, et al. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998; 93: 925-927.
60. 60 Sung JJ, Leung WK, Suen R, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997; 42: 2524-2528.
61. 61 Riemann JF, Schilling D, Schauwecker P, et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997; 46: 299-304.
62. 62 Santander C, Gravalos RG, Gomez-Cedenilla A, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent haemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996; 91: 1549-1552.
63. 63 Tytgat GNJ. Treatment of peptic ulcer. Digestion 1998; 59: 446-452.
64. 64 Peterson WL. Prevention of upper gastrointestinal bleeding. N Engl J Med 1994; 330: 428-429.
65. 65 Buckley M and the Irish Helicobacter pylori Study Group (Culhane A, Drumm B, Keane C, Moran AP, O'Connor HJ, Collins J, Kelleher D, McAvinchey D, Sloan J, O'Morain C). Guidelines for the management of Helicobacter pylori-related upper gastrointestinal diseases. Ir J Med Sci 1996; 165 (Suppl. 5): 1-11.
66. 66 Danesh J, Appleby P, Peto R. How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. Br Med J 1998; 316: 746-747.
67. 67 Karat D, Griffin SM. Bile reflux is important in eradicating Helicobacter pylori. Br Med J 1998; 317: 697.
68. 68 Khulusi S. Helicobacter pylori is merely suppressed by bile. Br Med J 1998; 317: 697.
69. th ed. Philadelphia: Saunders, 1993.
70. 70 Lee YT, Sung JJY, Choi CL, et al. Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol 1998; 93: 928-931.
71. 71 Leivonen M, Nordling S, Haglund C. The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease. Hepatogastroenterology. 1998; 45: 587-591.
72. 72 Martin IG, Diament RH, Dixon MF, Axon ATR, Johnston D. Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol 1995; 7: 207-209.
73. 73 Leivonen MK, Haglund CH, Nordling SFA. Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol 1997; 9: 371-374.
74. 74 Peetsalu M, Maaroos HI, Peetsalu A. Completeness of vagotomy, Helicobacter pylori colonization and recurrent ulcer 9 and 14 years after operation in duodenal ulcer patients. Eur J Gastroenterol Hepatol 1998; 10: 305-311.
75. 75 Venables CW. Helicobacter pylori and gastric surgery. Eur J Gastroenterol Hepatol 1995; 7: 197-199.
76. 76 Robles-Campos R, Lujan-Mompean JA, Parilla-Parico P, et al. Role of Helicobacter pylori infection and duodenogastric reflux in the pathogenesis of alkaline reflux gastritis after gastric operations. Surg Gynecol Obstet 1993; 176: 594-598.
77. 77 Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis after gastric resection. Gut 1995; 36: 351-353.
78. 78 Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 1997; 17:3893-3896.
79. 79 Safatle-Ribeiro AV, Ribeiro U Jr, Clarke MR, et al. Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 1999; 44: 243-252.
80. 80 Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels and gastric emptying in patients with gastric ulcer. Am J Gastroenterol 1997; 92: 1844-1848.
81. 81 Borody TJ, Clark IW, Andrews P, Hugh TB, Shortis NP. Eradication of Helicobacter pylori may not reverse severe gastric dysplasia. Am J Gastroenterol 1995; 90: 498-499.
82. 82 Genta R. Atrophy, metaplasia and dysplasia. Are they reversible? It J Gastroenterol Hepatol 1998; 30 (Suppl.2): s324-s325.
83. 83 Van der Hulst RWM, van der Ende A, Dekker FW, et al. Efect of helicobacter pylori eradication on gastritis in relation to CagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30.
84. 84 Maconi G, Vago L, Nebuloni E, Bianchi Porro G. Eradication of Helicobacter pylori, improvement of gastritis and the normalisation of the hyperproliferative state of gastric mucosa did not prevent a case of gastric cancer. J Clin Gastroenterol 1999; 28: 178-179.
85. 85 Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-642.